How Peptides Signal in the Body

A tiny chain of amino acids is injected into the fat of your belly. A few minutes later, cells in your pituitary gland start doing something they weren't doing before. How?

This is the question that trips up most people when they first read about peptides. If they're so small and specific, how do they know where to go? And once they arrive, how do they make anything happen? The answer is a surprisingly elegant system that the body uses constantly — peptides are just borrowing it.

Peptides don't enter cells

The first important fact: most peptides never actually go inside the cells they affect. They're too big and too charged to cross the fatty membrane that surrounds every cell. Instead, they stick to the outside.

Every cell in your body is studded with proteins called receptors — think of them as locks embedded in the cell's surface, with their keyholes facing outward. Each type of receptor is shaped to fit one specific signaling molecule. When that molecule (the "ligand") arrives and binds, the receptor changes shape. That shape change, on the inside of the cell, is the signal.

So peptides don't command cells directly. They knock on a door, and the door's handle — which pokes through into the cell — turns.

The most common machinery: GPCRs

Most peptides of interest in this community bind to a family of receptors called G-protein coupled receptors, or GPCRs. There are hundreds of them in your body. They're the target of something like a third of all prescription drugs, not just peptides.

Here's the mechanism in plain English:

1. Binding. The peptide slots into the outside face of the receptor.
2. Shape change. The receptor twists, which exposes a binding site on its inner face.
3. G-protein activation. A little molecular relay inside the cell — the G-protein — latches onto the receptor and splits into pieces.
4. Second messenger. Those pieces switch on enzymes that produce a flood of a small internal signal, usually cAMP or a calcium spike.
5. Downstream cascade. The second messenger activates other enzymes, which activate others, which eventually change what the cell is doing — secreting a hormone, making a protein, growing, dividing, firing an electrical signal.

A single peptide binding event can produce thousands of second-messenger molecules. That's why nanogram doses matter. The signal is amplified at every step.

A worked example: GH release

Consider a shot of sermorelin before bed. Sermorelin is a fragment of GHRH (growth hormone releasing hormone), the signal your hypothalamus normally uses to tell your pituitary to release growth hormone.

• Sermorelin reaches your pituitary through the bloodstream.
• It binds the GHRH receptor on somatotroph cells (the GH-producing cells).
• The receptor activates a G-protein (specifically Gs).
• Gs activates an enzyme called adenylyl cyclase, which cranks out cAMP.
• cAMP activates PKA, a kinase that phosphorylates other proteins.
• One of those proteins triggers the release of pre-stored growth hormone granules into the blood.

The peptide itself never entered a cell. It just nudged a door. The door did the rest.

Why this matters practically

Understanding the signaling model clears up a lot of common confusion:

Why peptides are so specific. A receptor is a three-dimensional shape. If the peptide doesn't fit that shape, nothing happens. This is why side effects tend to be narrower than with small-molecule drugs — a peptide physically can't bind receptors it wasn't shaped for.

Why timing matters. The signal doesn't last as long as the peptide does. Receptors desensitize, internalize, and reset. Hitting the same receptor constantly often works worse than pulsing it. This is why GH peptide protocols use pulses, not continuous infusions.

Why some peptides need cofactors. CJC-1295 and ipamorelin stack well together because they hit two different receptors (GHRH-R and the ghrelin receptor) that converge on GH release. Two signals into the same somatotroph produce more output than either alone.

Why dose doesn't scale linearly. Once receptors are saturated, adding more peptide does nothing. Some doses are high enough to cause desensitization — the cell pulls receptors off its surface to stop being screamed at.

Where to go next

• For the full architecture of the GH example, see The GH Axis, Explained.
• For how receptor occupancy translates to actual effects, the Pepperpedia entry on receptor binding goes deeper.
• If you want to understand why some peptides last minutes and others last days, read Half-Life and Why It Matters.
• For a refresher on what peptides are to begin with, start with What Are Peptides?.